Provided by Tiger Trade Technology Pte. Ltd.

Amgen

382.75
-8.5200-2.18%
Volume:1.55M
Turnover:596.53M
Market Cap:206.10B
PE:23.77
High:391.67
Open:387.84
Low:381.51
Close:391.27
52wk High:447.03
52wk Low:269.77
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.78
T/O Rate:0.29%
Dividend:9.80
Dividend Rate:2.56%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:17.63
PE(LYR):26.90

Loading ...

Amgen Price Target Maintained with a $400.00/Share by Cantor Fitzgerald

Dow Jones
·
Sep 08

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 08

Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley

Dow Jones
·
Sep 08

Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial

Reuters
·
Sep 08

Rothschild & Co Redburn Adjusts Price Target on Amgen to $225 From $235, Keeps Sell Rating

MT Newswires Live
·
Sep 08

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Dow Jones
·
Sep 08

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Reuters
·
Sep 08

Stocks to Watch: Amgen, Nike, Bloom Energy

Dow Jones
·
Sep 08

Amgen downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
Sep 08

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS
·
Sep 08

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

Movement Alert|Amgen Falls 5.08% in Pre-Market Trading, Novartis Lp(a) Heart Drug Phase III Failure Drags Down Peer Stocks

Market Focus
·
Sep 08

Movement Alert|Amgen Overnight Decline 5.27%, Dragged by Novartis Lp(a) Drug Trial Failure Casting Doubt on Cardiovascular Pipeline Thesis

Market Focus
·
Sep 08

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 07

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Stock News
·
Sep 07

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Dow Jones
·
Sep 06

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Reuters
·
Sep 05

Movement Alert|Amgen Falls 5.08% in After-Hours Trading, Trading at $409.94

Market Focus
·
Sep 05

Amgen is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 05